Reducing air pollution is linked to slowed brain aging and lower dementia riskJuly 28, 2021Alzheimer's & Cognition
First guidance on appropriate use of controversial Alzheimer’s drugJuly 28, 2021Alzheimer's & Cognition
More on GRADE: Cognitive deficits linked to CV risk factors in T2DJuly 27, 2021Alzheimer's & Cognition
Zero benefit of aducanumab for Alzheimer’s disease, expert panel rulesJuly 16, 2021Alzheimer's & Cognition
Contentious Alzheimer’s drug likely to get national coverage plan, CMS saysJuly 14, 2021Alzheimer's & CognitionBusiness of Medicine
FDA head calls for investigation into agency’s approval of aducanumab (Aduhelm)July 12, 2021Alzheimer's & Cognition
FDA updates label for controversial Alzheimer’s drug aducanumab (Aduhelm)July 8, 2021Alzheimer's & Cognition
Chronic stress and genetics can raise the risk of Alzheimer’s diseaseJuly 7, 2021Alzheimer's & Cognition
